alexa
Reach Us +44-1202068036
Chronic Myeloid Leukemia: Emergency Onset Followed By The Achievement Of Complete Cytogenetic And Major Molecular Responses And Long-term Survival | 19953
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Hematology & Blood Disorders

Vasile Musteata
Accepted Abstracts: J Blood Disorders Transf
DOI: 10.4172/2155-9864.S1.008
Abstract
C hronic myeloid leukemia (CML) may be associated with the life-threatening emergencies, including thrombotic and infectious complications, splenic infarcts, bleeding. A 21-year-old girl experienced an abrupt onset of the disease in June 2006, with a sharp pain in the projected area of the left ovary. She was hospitalized at the National Research and Practical Emergency Medicine Center with the diagnosis of left-sided ovarian apoplexy. The suturation of the left ovary was performed. The revealed splenomegaly, anemia and elevated leukocyte count required the consultation by hematologist from the Institute of Oncology. The patient was admitted to the Division of Hematology at the Institute of Oncology in June 2006 with the left upper abdominal quadrant fullness and anemic syndrome. Clinical examination and ultrasound scanning showed moderate splenomegaly and slight hepatomegaly. ECOG-WHO performance status score: 2. Blood count: Hb 85 g/l, er. 3.4 x 1012/l, leuk. 430.0 x 109/l, plt. 510.0 x 109/l, ESR 4 mm/h, with the shift to the left up to blast cells 9%. Bone marrow aspiration detected hypercellularity, myeloid hyperplasia (84.0%) and normal rate of blast cells (1.0%). Cytogenetic analysis and real- time quantitative PCR of the bone marrow cells revealed Ph chromosome and BCR-ABL transcript in 100%. Diagnosis: CML, chronic phase; Socal?s prognostic risk score: 0.78 (low-risk group). The patient underwent chemotherapy with hydroxyurea 3000 mg daily, with the achievement of partial hematologic response. In 2007, she started chemotherapy with imatinib mesylate at a dosage of 400 mg daily, with the achievement of complete hematologic response and minor cytogenetic response (Ph chromosome: 60%). ECOG-WHO performance status score hitted 0. Due to the persistence of Ph chromosome-bearing bone marrow cells the dosage of imatinib was increased up to 600 mg daily. The repeated FISH analysis of the bone marrow cells didn?t revealed Ph chromosome. The real-time quantitative PCR showed the major molecular response (BCR-ABL transcript: 0.03%). Overall survival accounts 95 months, and relapse-free survival?54 months (by June 2014). The patient continues her professional activity, with a good life quality.
Biography
Vasile Musteata completed his PhD and MPH at the age of 30 years and 39 years respectively after the Postgraduate studies at the State University of Medicine and Pharmacy ?N. Testemitanu? from the Republic of Moldova. He is an Associate Professor and deputy Head for education at the University Department of Oncology, Hematology and Radiotherapy, the GIPAP manager, EACR Ambassador, iCMLf representative for Moldova and the European LeukemiaNet member. He has published more than 100 articles and abstracts in reputed journals/abstract books, and has been serving as an Editorial Board Member of the Journal of BUON.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version